At the SPbU Start-Up – 2018, the Diaplast team has been working on a new express system for checking blood sugar levels that no longer requires finger pricks. It is a patch that tests blood glucose in sweat. The innovation is expected to cost about 200 rubles.
The system is designed to work as the pregnancy test does – it will have two lines: the first one is a control line that tells whether the system properly works and the second line is an indicator line which appears when the glucose level is higher than 6 mmol/L.
“You should take the test when before you eat in the morning, — said the author of the idea, a student in Medicine Anna Malkova. — You wake up in the morning, stick the patch, and do what you want. Meanwhile, it causes sweat to accumulate under the patch and in 10-15 minutes it measures the glucose level. You’d better avoid doing vigorous activities as physically-demanding exercises actively burn glucose”.
The innovation is based on aptamers that are oligonucleotide molecules that bind to a specific target molecule. Today, these molecules have application in ophthalmology and targeted drug delivery in cancer therapy. The students suggested using aptamers as a material of diagnostics. Although it is a new field for research, aptamers have a potential for research and industry.
The project primarily aims to improve early diabetes diagnostics: to make a test more convenient and affordable to ensure that people at risk can have early diagnostic testing. Diabetes, according to the World Health Organization, is among the major causes of blindness, nephropathy, and heart attacks. In 1980, the number of people diagnosed with diabetes equaled 108 mln, which increased up to 422 mln in 2014. In Russia, as many as 4.3 mln people are reported to have been diagnosed with diabetes, yet the specialists say that there are at least 8 mln.
You can buy the test system in the pharmacy, just like the pregnancy test. Obviously, the system will be further used in hospitals, and the doctors will be able to test your blood glucose levels without pricking your finger.
Student in Law Maria Evsukova
The market of non-invasive diagnostics is on the rise. The specialists from the USA are also developing a new non-invasive glucose monitor. It is a multiple-use device that incorporates a system of dozed insulin injections that you can carry with your for a long time. All these make the device costly. The innovation our students are developing is completely different: it is a single-use device and is estimated to cost 200 rubles.
The team is headed Maksim Kuznetsov, a student in Medicine, and also includes Viktor Alekseev, a student in Economics.